Close
Nordic 9Nordic 9

Perceptive Advisors (investor - Venture Capital)

United States perceptivelife.com
See something wrong or missing? Let us know
Offices:New York

Perceptive Advisors is an American investment firm focused on making public and private investments in the healthcare and biotechnology industries.

Average round investment:103.21M USD
Average number per year:3.0
Distribution: 2024 (3)
Portfolio companies: Belgium Confo TherapeuticsUnited Kingdom Pheon TherapeuticsIreland Mainstay Medical
Mostly invests in: Belgium Belgium (1) Health services (3)

3 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Perceptive Advisors

Name Criteria
United States Rock Springs Capital
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
United Kingdom Novator Partners
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 3.1
  • Active last 12 months: Yes
United States Fidelity Investments
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Belgium, United Kingdom
  • Average number of deals per year: 3.1
  • Active last 12 months: Yes
United States Menlo Ventures
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Ireland
  • Average number of deals per year: 3.2
  • Active last 12 months: Yes
United States New Enterprise Associates
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Ireland
  • Average number of deals per year: 3.3
  • Active last 12 months: Yes
United Kingdom Advent Life Sciences
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
United States Iconiq Capital
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
United Kingdom Syncona
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
Netherlands Prosus Ventures
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Ireland
  • Average number of deals per year: 3.7
  • Active last 12 months: Yes
France Sanofi Ventures
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Top